Immune regulation in adjuvant-induced arthritis: Possible implications for innovative therapeutic strategies in arthritis

Arthritis and Rheumatism

Volumn 48, Issue 7, 2003, Pages 1788-1796

  Van Eden, Willem ^a,c   Waksman, Byron H ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Infectious Diseases and Immunology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT ARTHRITIS; ANTIGEN RECOGNITION; CELLULAR IMMUNITY; CROSS REACTION; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; B-LYMPHOCYTES; CROSS REACTIONS; HUMANS; T-LYMPHOCYTES;

EID: 0037667309     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11077     Document Type: Review

References (87)

1. Pearson CM. Development of arthritis, periarthritis and periostitis in rats given adjuvant. Proc Soc Exp Biol Med 1956;91:95-101.
2. Pearson CM, Wood FD. Studies of polyarthritis and other lesions induced in rats by injection of mycobacterial adjuvant. I. General clinical and pathologic characteristics and some modifying factors. Arthritis Rheum 1959;2:440-59.
3. Waksman BH. Experimental allergic encephalomyelitis and the "autoallergic" diseases. Int Arch Allergy 1959;14 Supp:1-87.
4. Waksman BH. Auto-immunization and mechanisms of autoimmunity. Medicine 1962;41:92-141.
5. Pearson CM, Waksman BH, Sharp JT. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes: comparison of the experimental process with human disease. J Exp Med 1961;113:485-510.
6. Waksman BH, Pearson CM, Sharp JT. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. J Immunol 1960;85:403-17.
7. Flax MH, Waksman BH. Delayed cutaneous reactions in the rat. J Immunol 1962;89:496-504.
8. Waksman BH, Wennersten C. Passive transfer of adjuvant arthritis in rats with living lymphoid cells of sensitized donors. Int Arch Allergy 1963;23:129-39.
9. Whitehouse DJ, Whitehouse MW, Pearson CM. Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes. Nature 1969;224:1322.
10. 3-thymidine. Yale J Biol Med 1964;37:195-203.
11. Putnam DA, Lubaroff DM, Waksman BH. Bone marrow as source of cells in reactions of cellular hypersensitivity. III. Adjuvant arthritis in the rat. Arthritis Rheum 1968;11:112-3.
12. Waksman BH. A comparative histopathologic study of delayed hypersensitive reactions. In: Wolstenholme GEW, O'Connor M, editors. Ciba foundation symposium on cellular aspects of immunity. London: Churchill; 1960. p. 280-322.
13. Waksman BH. Delayed hypersensitive reactions: a growing class of immunologic phenomena. J Allergy 1960;31:468-75.
14. Holoshitz J, Naparstek Y, Ben Nun A, Cohen IR. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983;219:56-8.
15. Cohen IR, Holoshitz J, van Eden W, Frenkel A. T lymphocyte clones illuminate pathogenesis and affect therapy of experimental arthritis. Arthritis Rheum 1985;28:841-5.
16. Cohen IR. Autoimmunity to hsp65 and the immunologic paradigm. Adv Intern Med 1992;37:295-311.
17. Van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A 1985;82:5117-20.
18. Arnason BG, Jankovic BD, Waksman BH, Wennersten C. Role of the thymus in immune reactions in rats. II. Suppressive effect of thymectomy at birth on reactions of delayed (cellular) hypersensitivity and the circulating small lymphocyte. J Exp Med 1962;116:177-86.
19. Waksman BH. Immune regulation in adjuvant disease and other arthritis models: relevance to pathogenesis of chronic arthritis. Scand J Immunol 2002;56:12-34.
20. Ferrick DA, Sydora B, Wallace V, Gemmell-Hori L, Kronenberg M, Mak TW. Self-reactive gamma delta T lymphocytes: implications for T-cell ontogeny and reactivity. Immunol Rev 1991;120:51-69.
21. Pelegri C, Kuhnlein P, Buchner E, Schmidt CB, Franch A, et al. Depletion of γ/δ T cells does not prevent or ameliorate, but rather aggravates, rat adjuvant arthritis. Arthritis Rheum 1996;39:204-15.
22. Wilbrink B, Holewijn M, Bijlsma JW, Van Roy JL, van der Zee R, Boog CJ, et al. Antigen-activated T cells inhibit cartilage proteoglycan synthesis independently of T-cell proliferation. Scand J Immunol 1992;36:733-43.
23. Bush KA, Walker JS, Lee CS, Kirkham BW. Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin Exp Immunol 2001;123:487-95.
24. Szekanecz Z, Halloran MM, Volin MV, Woods JM, Strieter RM, Kenneth Haines G 3rd, et al. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis. Arthritis Rheum 2000;43:1266-77.
25. Konttinen YT, Hukkanen M, Segerberg M, Rees R, Kemppinen P, Sorsa T, et al. Relationship between neuropeptide immunoreactive nerves and inflammatory cells in adjuvant arthritic rats. Scand J Rheumatol 1992;21:55-9.
26. Kojima T, Mwale F, Yasuda T, Girard C, Poole AR, Laverty S. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Arthritis Rheum 2001;44:120-7.
27. Van Eden W, Thole JE, van der Zee R, Noordzij A, van Embden JD, Hensen EJ, et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988;331:171-3.
28. Van Eden W. Heat shock protein in autoimmune arthritis: a critical contribution based on the adjuvant arthritis model. APMIS 1990;98:383-94.
29. Van Eden W. Heat-shock proteins as immunogenic bacterial antigens with the potential to induce and to regulate autoimmune arthritis. Immunol Rev 1991;121:5-28.
30. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 1991;4:871-80.
31. Holmdahl R, Goldschmidt TJ, Kleinau S, Kvick C, Jonsson R. Arthritis induced in rats with adjuvant oil is a genetically restricted α/β-T-cell dependent autoimmune disease. Immunology 1992;76: 197-202.
32. Vingsbo C, Sahlstrand P, Brun JG, Jonsson R, Saxne T, Holmdahl R. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol 1996;149:1675-83.
33. Carlsson BC, Jansson AM, Larsson A, Bucht A, Lorentzen JC. The endogenous adjuvant squalene can induce a chronic T cell mediated polyarthritis in rats. Am J Pathol 2000;156:2057-65.
34. Francis JN, Lamont AG, Thompson SJ. The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis. Immunology 2000;99:338-44.
35. Dulphy N, Peyrat MA, Tieng V, Douay C, Rabian C, Tamousza R, et al. Common intra-articular T cell expansions in patients with reactive arthritis: identical beta-chain junctional sequences and cytotoxicity toward HLA-B27. J Immunol 1999;162:3830-39.
36. Mertz AK, Wu P, Sturniolo T, Stoll D, Rudwaleit M, Lauster R, et al. Multispecific CD4+ T cell response to a single 12-mer epitope of the immunodominant heat-shock protein 60 of Yersinia enterocolitica in Yersinia-triggered reactive arthritis: overlap with the B27-restricted CD8 epitope, functional properties, and epitope presentation by multiple DR alleles. J Immunol 2000;164:1529-37.
37. Holoshitz J, Klajman A, Drucker I, Lapidot Z, Yaretzky A, Frenkel A, et al. T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria crossreactive with cartilage. Lancet 1986;2:305-9.
38. Holoshitz J, Koning F, Coligan JE, De Bruyn J, Strober S. Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid. Nature 1989;339:226-9.
39. Gery I, Waksman BH. Studies on the mechanism whereby adjuvant disease is suppressed in rats pretreated with mycobacteria. Int Arch Allergy 1967;31:57-68.
40. Van Eden W, Anderton SM, van der Zee R, Prakken BJ, Broeren CP, Wauben MH. (Altered) self peptides and the regulation of self reactivity in the peripheral T cell pool. Immunol Rev 1996;149:55-73.
41. Van Eden W. Immunity to heat shock proteins and arthritic disorders. Infect Dis Obstet Gynecol 1999;7:49-54.
42. Wauben MHM, Boog CJP, van der Zee R, Joosten I, Schlief A, van Eden W. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone. J Exp Med 1992;176:667-77.
43. Prakken BJ, Roord S, van Kooten PJS, Wagenaar JPA, van Eden W, Albani S, et al. Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope. Arthritis Rheum 2002;46:1937-46.
44. Van Eden W, van der Zee R, Taams LS, Prakken AB, van Roon J, Wauben MH. Heat-shock protein T-cell epitopes trigger a spreading regulatory control in a diversified arthritogenic T-cell response. Immunol Rev 1998;164:169-74.
45. Anderton SM, van der Zee R, Prakken B, Noordzij A, van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med 1995;181:943-52.
46. Moudgil KD, Chang TT, Eradat H, Chen AM, Gupta RS, Brahn E, et al. Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J Exp Med 1997;185:1307-16.
47. Wendling U, Paul L, van der Zee R, Prakken B, Singh M, van Eden W. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol 2000;164:2711-7.
48. Prakken BJ, Wauben M, van Kooten P, Anderton S, van der Zee R, Kuis W, et al. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci U S A 1997;94:3284-9.
49. Feige U, van Eden W. Infection, autoimmunity and autoimmune disease. Experientia 1996;77:359-73.
50. Van Tienhoven E, van Kooten PJ, Veenstra JG, van der Hage MH, van Eden W, Broeren CP. Induction of experimental autoimmune arthritis by a public epitope of the T cell receptor variable alpha domain of an arthritogenic T cell clone. Eur J Immunol 2000;30:2164-71.
51. Broeren CPM, Lucassen MA, van Stipdonk MJB, van der Zee R, Boog CJP, Kusters JG, et al. CDR1 T-cell receptor β-chain peptide induces major histocompatibility complex class II-restricted T-T cell interactions. Proc Natl Acad Sci U S A 1994;91:5997-6001.
52. Grippenberg-Lerche C, Toivanen A, Toivanen P. Yersinia-associated arthritis in rats: effect of 65 kDa heat shock protein, bovine serum albumin and incomplete Freund's adjuvant. Clin Exp Rheumatol 1995;13:321-5.
53. Paul AG, van Der Zee R, Taams LS, van Eden W, A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis? Int Immunol 2000;12:1041-50.
54. Thompson SJ, Francis JN, Siew LK, Webb G, Jenner R, Colston PJ, et al. An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. J Immunol 1998;160:4628-34.
55. Kingston AE, Hicks CA, Colston MJ, Billingham ME. A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol 1996;103:77-82.
56. Prakken BJ, Wendling U, van der Zee R, Rutten VP, Kuis W, van Eden W. Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol 2001;167:4147-53.
57. Tanaka S. Activation of T cells recognizing an epitope of heat shock protein 70 can protect against rat adjuvant arthritis. J Immunol 1999;163:5560-5.
58. Boog CJ, de Graeff-Meeder ER, Lucassen MA, van der Zee R, Voorhorst-Ogink MM, van Kooten PJ, et al. Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis. J Exp Med 1992;175:1805-10.
59. Santori FR, Brown SM, Vukmanovic S. Genomics-based identification of self-ligands with T cell receptor-specific biological activity. Immunol Rev 2002;190:146-60.
60. Kingsbury DJ, Mear JP, Witte DP, Taurog JD, Roopenian DC, Colbert RA. Development of spontaneous arthritis in β2-microglobulin-deficient mice without expression of HLA-B27: association with deficiency of endogenous major histocompatibility complex class I expression. Arthritis Rheum 2000;43:2290-6.
61. Guerassimov A, Zhang Y, Banerjee S, Cartman A, Webber C, Esdaile J, et al. Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 1998;25:1480-4.
62. Ullmansky R, Cohen CJ, Szafer F, Moallem E, Fridlender ZG, Kashi Y, et al. Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion. J Immunol 2002;168:6463-9.
63. Ragno S, Colston MJ, Lowrie DB, Winrow VR, Blake DR, Tascon R. Protection of rats from adjuvant arthritis by immunization with naked DNA encoding for mycobacterial heat shock protein 65. Arthritis Rheum 1997;40:277-83.
64. Quintana FJ, Carmi P, Mor F, Cohen IR. Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J Immunol 2002;169:3422-8.
65. Wills-Karp M, Santeliz J, Karp CL. The germless theory of allergic disease: revisiting the hygiene hypothesis. Nat Rev Immunol 2001;1:69-75.
66. Khoury SJ, Lider O, al-Sabbagh A, Weiner HL. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide. Cell Immunol 1990;131:302-10.
67. Sudo N, Sawamura S, Tanaka K, Aiba Y, Kubo C, Koga Y. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J Immunol 1997;159:1739-45.
68. Nieuwenhuis EES, Visser MR, Kavelaars A, Cobelens PM, Fleer A, Harmsen W, et al. Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli. Arthritis Rheum 2000;43:2583-9.
69. Cobelens PM, Heijnen CJ, Nieuwenhuis EES, Kramer PPG, van der Zee R, van Eden W, et al. Treatment of adjuvant-induced arthritis by oral administration of mycobacterial Hsp65 during disease. Arthritis Rheum 2000;43:2694-702.
70. Cobelens PM, Kavelaars A, Vroon A, Ringeling M, van der Zee R, van Eden W, et al. The beta2-adrenergic agonist salbutamol potentiates oral induction of tolerance suppressing adjuvant arthritis and antigen-specific immunity. J Immunol 2002;169:5028-35.
71. Van Eden W, Wendling U, Paul L, Prakken B, van Kooten P, van der Zee R. Arthritis protective regulatory potential of self-heat shock protein cross-reactive T cells. Cell Stress Chaperones 2000;5:452-7.
72. Waksman B, Isakovic K. Effect of sensitization to BSA on adjuvant disease in normal and neonatally thymectomized rats. Proc Soc Exp Biol Med 1965;119:676-8.
73. Gery I, Waksman BH. Competition of antigens in adjuvant disease of rats. Arthritis Rheum 1967;10:240-4.
74. McMenamin C, McKersey M, Kuhnlein P, Hunig T, Holt PG. Gamma delta T cells down-regulate primary IgE responses in rats to inhaled soluble protein antigens. J Immunol 1995;154:4390-4.
75. Sano G, Hafalla JC, Morrot A, Abe R, Lafaille JJ, Zavala F. Swift development of protective effector functions in naïve CD8+ T cells against malaria liver stages. J Exp Med 2001;194:173-9.
76. Hogervorst EJ, Schouls L, Wagenaar JP, Boog CJ, Spaan WJ, van Embden JD, et al. Modulation of experimental autoimmunity: treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus. Infect Immun 1991;59:2029-35.
77. Lopez-Guerrero JA, Ortiz MA, Paez E, Bernabeau C, Lopez-Bote JP. Therapeutic effect of recombinant vaccinia virus expressing the 60-kd heat-shock protein on adjuvant arthritis. Arthritis Rheum 1994;37:1462-7.
78. Goupille P, Poet JL, Jattiot F, Mattei JP, Vedere V, Tonolli-Serabian I, et al. Three cases of arthritis after BCG therapy for bladder cancer. Clin Exp Rheumatol 1994;12:195-7.
79. De Graeff-Meeder ER, van der Zee R, Rijkers GT, Schuurman HJ, Kuis W, Bijlsma JW, et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet 1991;337:1368-72.
80. De Graeff-Meeder ER, van Eden W, Rijkers GT, Prakken BJ, Kuis W, Voorhorst-Ogink MM, et al. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest 1995;95:934-40.
81. Prakken AB, van Eden W, Rijkers GT, Kuis W, Toebes EA, de Graeff-Meeder ER, et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum 1996;39:1826-32.
82. Gerli R, Pitzalis C, Bistoni O, Falini B, Costantini V, Russano A, et al. CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. J Immunol 2000;164:4399-407.
83. Life P, Hassell A, Williams K, Young S, Bacon P, Southwood T, et al. Responses to gram negative enteric bacterial antigens by synovial T cells from patients with juvenile chronic arthritis: recognition of heat shock protein HSP60. J Rheumatol 1993;20:1388-96.
84. Corrigall VM, Bodman-Smith MD, Fife MS, Canas B, Myers LK, Wooley P, et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol 2001;166:1492-8.
85. Van Roon J, van Eden W, van Roy J, Lafeber F, Bijlsma JWJ. Stimulation of suppressive T cell responses by human but not bacterial 60 kDa heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest 1997;100:459-63.
86. Bloemendal A, van der Zee R, Rutten VP, van Kooten PJ, Farine JC, van Eden W. Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70: modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA). Clin Exp Immunol 1997;110:72-8.
87. Farine JC, Meredith M. Subreum and rheumatoid arthritis: a novel immunomodulating drug from Natural Product Developments. In: Rainsford KD, editor. Advances in antirheumatic therapy. Boca Raton (FL): CRC Press; 1996, p. 167-80.